Wallingford, CT, United States of America

Kyle J Eastman

USPTO Granted Patents = 20 (Patent Applications = 11)

EPO Patents = 10 (Patent Applications = 22)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 72(Granted Patents)

Location History:

Killingsworth, CT (US) (2016)
Killingworth, CT (US) (2012 - 2018)
Wallingford, CT (US) (2018 - 2023)
New Haven, CT (US) (2021 - 2024)

Company Filing History:

10 out of 104

Achillion Pharmaceuticals, Inc.

patents

6 out of 3,684

Bristol-myers Squibb Compnay

patents

4 out of 42

Viiv Healthcare UK (no.5) Limited

patents

Years Active: 2012-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12479856 - Pharmaceutical compounds for the treatment of complement mediated disorders (2025-11-25),

2. 12297205 - Macrocyclic compounds for treatment of medical disorders (2025-05-13),

3. 12162860 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2024-12-10),

4. 12006307 - Pharmaceutical compounds for treatment of medical disorders (2024-06-11),

5. 11814391 - Macrocyclic compounds for the treatment of medical disorders (2023-11-14),

6. 11718626 - Macrocyclic compounds for treatment of medical disorders (2023-08-08),

7. 11708351 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2023-07-25),

8. 11447465 - Pharmaceutical compounds for treatment of medical disorders (2022-09-20),

9. 11084800 - Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders (2021-08-10),

10. 11053253 - Macrocyclic compounds for treatment of medical disorders (2021-07-06),

11. 10351546 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2019-07-16),

12. 10214534 - Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C (2019-02-26),

13. 10189816 - Substituted pyridines as inhibitors of human immunodeficiency virus replication (2019-01-29),

14. 10065953 - Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication (2018-09-04),

15. 9957278 - Furopyridine compounds for the treatment of hepatitis C (2018-05-01),

Title: The Innovative Journey of Kyle J Eastman

Introduction: Kyle J Eastman is a pioneering inventor based in New Haven, CT, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kyle J Eastman holds several patents in the realm of artificial intelligence and renewable energy technologies, showcasing her commitment to creating a sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Kyle J Eastman has led numerous projects that have revolutionized the way we approach complex challenges in various industries.

Collaborations: Throughout her career, Kyle J Eastman has collaborated with leading research institutions and tech companies to bring her ideas to life, fostering a culture of innovation and creativity.

Conclusion: Kyle J Eastman's dedication to pushing the boundaries of what is possible through her inventive spirit continues to inspire the next generation of inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.